Insurance M&A to rebound in H2 2022: PwC

24 June 2022

X
LinkedIn
Email
Show more sharing options

Despite a drop-off in dealmaking in early 2022, insurance M&A is to ramp up again in the latter part of the year, according to PwC.

The company noted that insurance activity cooled at the end of an active 2021 and early this year due to geopolitical instability, rising interest rates and inflation.

Enter your e-mail to claim a free trial:

Uncover exclusive insights tailored for insurance leaders

Stay Informed: Access exclusive industry insights
Gain a competitive advantage: Hear first about tactical developments
Make better decisions: Understand market dynamics in crucial lines of business

Take a free trial Already a subscriber? Login now

Insurance M&A to rebound in H2 2022: PwC

Despite a drop-off in dealmaking in early 2022, insurance M&A is to ramp up again in the latter part of the year, according to PwC.

Uncover exclusive insights tailored for insurance leaders

Topics

Most Recent

Ambridge accused of ‘toxic’ work environment by ex-employees MGA Devonshire founders

Convex in ‘evolution not revolution’ phase: Brand

Londonitis: Beazley and Hiscox should look hard at their London listings

The Week in 90 Seconds: Willis Re-boot; Q1 results; Broker start-ups

Talanx reports prelim net income of EUR572mn in Q1

Behind the Headlines: Israel escalation and Convex's Paul Brand on building and running a $4bn (re)insurer

Marsh McLennan launches global alternative risk solutions practice

Insurance M&A to rebound in H2 2022: PwC

Despite a drop-off in dealmaking in early 2022, insurance M&A is to ramp up again in the latter part of the year, according to PwC.

Login to continue

Uncover exclusive insights tailored for insurance leaders

Topics

Ambridge accused of ‘toxic’ work environment by ex-employees MGA Devonshire founders

Convex in ‘evolution not revolution’ phase: Brand

Londonitis: Beazley and Hiscox should look hard at their London listings

The Week in 90 Seconds: Willis Re-boot; Q1 results; Broker start-ups

Talanx reports prelim net income of EUR572mn in Q1

Behind the Headlines: Israel escalation and Convex's Paul Brand on building and running a $4bn (re)insurer

Marsh McLennan launches global alternative risk solutions practice